ArticleFrontiers in oncology2024

DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis.

Shiyu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.